Trump, Kennedy Recalibrate MAHA Vaccine Agenda Ahead of 2026 Midterms

Axios reports that the Trump administration is quietly steering its 'Make America Healthy Again' health agenda away from high‑profile vaccine battles as the 2026 midterms approach, despite years of influence from vaccine‑skeptic allies inside HHS. Recent moves include the departure of CDC official Ralph Abraham, who called COVID vaccines 'dangerous,' the promotion of drug‑pricing negotiator Chris Klomp into a more powerful HHS role, and a State of the Union that focused on costs and prescription drugs while omitting vaccines and other core MAHA planks. HHS Secretary Robert F. Kennedy Jr. has been emphasizing food additives and dietary guidelines on the campaign trail rather than the administration’s earlier efforts to shrink the childhood vaccine schedule and overhaul a key advisory committee, and the FDA reversed course to review Moderna’s mRNA flu shot after initially declining, reportedly under White House pressure. At the same time, MAHA-aligned figures still hold influential posts, including surgeon general nominee Casey Means, who told senators vaccines save lives but refused to unequivocally urge parents to vaccinate, and a Kennedy‑stacked vaccine advisory panel that has rescheduled a meeting to discuss COVID vaccine injuries and long COVID. The piece underscores a widening split between political strategists who see overt vaccine skepticism as a midterm liability and core MAHA activists who view unfinished vaccine and chemical‑exposure fights as central to the project and are pushing back on claims their agenda is unpopular.